Resource Mobilization

Share this page

Twitter Facebook
The Global Fund / John Rae

Funding is critical to ending AIDS, tuberculosis and malaria as epidemics.

The Global Fund pools the world’s resources to invest strategically in programs to fight these diseases. Together as a partnership of governments, the private sector, civil society and people affected by the diseases, we are committed to successfully funding our efforts – to ending the epidemics.

The Global Fund raises funding in three-year cycles known as Replenishments.

From Replenishment to Replenishment, financing comes primarily from the public sector, with approximately 95 percent of total funding coming from donor governments. The remaining 5 percent comes from the private sector, private foundations and innovative financing initiatives.

Every donor's pledges and contributions since the founding of the Global Fund are available in our Pledges and Contributions report:

  • Pledges and Contributions
    download in English

Sixth Replenishment

The Global Fund’s Sixth Replenishment raises funding for 2020 through 2022. France will host the Replenishment Conference in October 2019 to raise new funds and mobilize partners toward ending AIDS, TB and malaria by 2030 in alignment with the Sustainable Development Goals.

For the Sixth Replenishment, the Global Fund is calling on the world to step up the fight against HIV, TB and malaria. The Replenishment seeks to raise at least US$14 billion to help save 16 million lives, avert 234 million infections and help the world get back on track to end these diseases.

Learn more


Each Replenishment, public and private sector donors provide financial and other resources necessary to end the epidemics.

Government donors

More than 60 countries across the world have made contributions to the Global Fund, accelerating the fight against the three diseases.

Learn more

Private and nongovernment partners

The Global Fund’s striking progress is achieved through our unique partnership model in which private sector and nongovernment partners play a vital role. With new, innovative solutions to and partners in health financing, we can move faster to end these diseases.

Learn more

Published 22 January 2019